KR20110052185A - Process of fermentated tomato using lactic acid bacteria and its product - Google Patents
Process of fermentated tomato using lactic acid bacteria and its product Download PDFInfo
- Publication number
- KR20110052185A KR20110052185A KR1020090109126A KR20090109126A KR20110052185A KR 20110052185 A KR20110052185 A KR 20110052185A KR 1020090109126 A KR1020090109126 A KR 1020090109126A KR 20090109126 A KR20090109126 A KR 20090109126A KR 20110052185 A KR20110052185 A KR 20110052185A
- Authority
- KR
- South Korea
- Prior art keywords
- tomato
- pulp
- lactic acid
- acid bacteria
- fermented
- Prior art date
Links
- 240000003768 Solanum lycopersicum Species 0.000 title claims abstract description 93
- 235000007688 Lycopersicon esculentum Nutrition 0.000 title claims abstract description 92
- 238000000034 method Methods 0.000 title claims abstract description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 50
- 239000004310 lactic acid Substances 0.000 title claims description 25
- 235000014655 lactic acid Nutrition 0.000 title claims description 25
- 241000894006 Bacteria Species 0.000 title claims description 23
- 230000008569 process Effects 0.000 title claims description 17
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 47
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 46
- 235000012661 lycopene Nutrition 0.000 claims abstract description 46
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 46
- 239000001751 lycopene Substances 0.000 claims abstract description 46
- 229960004999 lycopene Drugs 0.000 claims abstract description 46
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 46
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 13
- 239000007787 solid Substances 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- 238000000855 fermentation Methods 0.000 claims description 21
- 230000004151 fermentation Effects 0.000 claims description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229920000858 Cyclodextrin Polymers 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 7
- 241000283690 Bos taurus Species 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 5
- 206010052428 Wound Diseases 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 241000192132 Leuconostoc Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 235000020299 breve Nutrition 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 230000001766 physiological effect Effects 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 241000186660 Lactobacillus Species 0.000 abstract description 9
- 238000004108 freeze drying Methods 0.000 abstract description 9
- 229940039696 lactobacillus Drugs 0.000 abstract description 9
- 235000015193 tomato juice Nutrition 0.000 abstract description 8
- 238000001914 filtration Methods 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 230000005070 ripening Effects 0.000 abstract 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 230000008859 change Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 108010063907 Glutathione Reductase Proteins 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 11
- 229960003180 glutathione Drugs 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 102000016938 Catalase Human genes 0.000 description 8
- 108010053835 Catalase Proteins 0.000 description 8
- 102000006587 Glutathione peroxidase Human genes 0.000 description 8
- 108700016172 Glutathione peroxidases Proteins 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 108010024636 Glutathione Proteins 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000003969 glutathione Nutrition 0.000 description 7
- 102000005720 Glutathione transferase Human genes 0.000 description 6
- 108010070675 Glutathione transferase Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000008176 lyophilized powder Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010060862 Prostate cancer Diseases 0.000 description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical class CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000003976 gap junction Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000011899 heat drying method Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5112—Cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/712—Vitamin E
Abstract
Description
본 발명은 물리적 처리로 얻은 토마토 과육 펄프를 농축하고, 열처리한 후 유산균을 이용하여 발효처리하고, 이를 안정화 보조제 첨가와 함께 동결-분말화한 토마토의 가공방법 및 그 가공된 발효 토마토에 관한 것이다. The present invention relates to a method for processing a tomato pulp obtained by physical treatment, concentrated and heat treated, followed by fermentation using lactic acid bacteria, and freeze-powdered tomatoes with a stabilizing aid and processed fermented tomatoes thereof.
토마토나 수박 등을 붉게 만드는데 관여하는 색소인 리코펜(lycopene)은 비타민C, 비타민E, 카로틴 등과 함께 심혈관 질환을 예방하고, 항암 효과를 발휘하는 강력한 항산화제 역할을 한다고 알려져 있다. 특히 토마토에 함유된 리코펜은 항산화 식품인 당근에 함유된 베타카로틴의 두배에 달하는 항산화력을 자랑한다. 또한, 노화방지, 항암효과(전립선암), 심혈관질환 예방 및 혈당저하 효과를 나타낸다. 특히 암세포 성장을 도모하는 주요 조절 인자인 IGF-1(insulin like growth factors)인자를 강력하게 억제하며, 단백질 43효소를 자극하여 세포 간 연락장치(gap junction)를 발현시키는데, 세포간 연락장치의 발현은 암의 억제와 깊은 연관이 있다. 동물이나 암세포를 이용한 일부 실험에선 폐암, 간암, 위암, 유방암, 자궁경부암, 대장암, 방광암, 췌장암 등에도 효과를 보였으며, 사람을 대상으로 한 임상 실험에서는 유방암, 전립선암에 대해 탁월한 방어기능을 가지고 있는 것으로 보고하였다. 특히 육종암과 전립선암에 효과가 있다고 알려져 있다.Lycopene, a pigment that is involved in making tomatoes and watermelon red, is known to act as a powerful antioxidant that prevents cardiovascular diseases and exerts anti-cancer effects along with vitamin C, vitamin E and carotene. Lycopene, especially in tomatoes, has twice as much antioxidant activity as beta-carotene in carrots. In addition, anti-aging, anti-cancer effect (prostate cancer), cardiovascular disease prevention and hypoglycemic effect. In particular, it strongly inhibits IGF-1 (insulin like growth factors) factor, which is a major regulator of cancer cell growth, and stimulates protein 43 enzyme to express gap junctions. Is deeply linked to cancer suppression. Some experiments using animal or cancer cells have shown effectiveness in lung cancer, liver cancer, stomach cancer, breast cancer, cervical cancer, colon cancer, bladder cancer, pancreatic cancer, and clinical trials in humans showed excellent protection against breast cancer and prostate cancer. Reported as having. It is known to be effective against sarcoma and prostate cancer.
리코펜은 열을 가할 경우 인체에 더 잘 흡수된다. 리코펜은 트랜스형과 시스형의 두가지 이성질체를 갖고 있는데, 열을 가할 경우 인체에 더 잘 흡수되는 시스형 이성질체로 변화해 체내 흡수율이 높아진다. 이와 관련하여, 도 1(인용자료 : John Shi 등(2002) Neutraceutical & Foods, 17:179-183)를 보면, 100℃ 미만에서는 트랜스형이 시스형으로 구조가 전환되며, 총 리코펜 함량에는 큰 변화가 없지만, 190℃에서는 총 리코펜 함량이 상당히 감소하며, 트랜스형과 시스형 함량이 큰 폭으로 줄어드는 것을 알 수 있다.Lycopene is better absorbed by the body when heated. Lycopene has two types of isomers, trans and cis, which change to cis isomers that are better absorbed by the human body when heated. In this regard, FIG. 1 (quotation: John Shi et al. (2002) Neutraceutical & Foods, 17: 179-183), below 100 ℃ transforms the trans form into a cis form, a significant change in the total lycopene content However, it can be seen that at 190 ° C., the total lycopene content is significantly reduced, and the trans and cis-type contents are greatly reduced.
또한, 리코펜은 빛의 강도에 따라 트랜스형의 함량이 급격히 줄어들어, 빛에 민감한 물질임을 알 수 있다. 또한, 리코펜은 에테르, 석유에테르, 헥산에 약간 녹고, 클로로포름, 벤젠에는 잘 녹으며, 메탄올, 에탄올에는 거의 녹지 않으며, 지용성이기 때문에 기름에 조리했을 때 더 잘 흡수된다. In addition, the lycopene content of the trans form is rapidly reduced according to the light intensity, it can be seen that the material sensitive to light. Lycopene is also slightly soluble in ether, petroleum ether and hexane, soluble in chloroform and benzene, hardly soluble in methanol and ethanol, and absorbed better when cooked in oil because it is fat-soluble.
이러한 토마토 내 리코펜 성분을 추출하는 방법에 관한 국내외 특허출원을 살펴보면, 한국 특허출원 공개번호 제2006-0070846호에는 산소 호흡 대사 과정에서 활성 산소의 생성을 억제함으로써 우수한 항산화 효과를 나타내는 리코펜을 초임계 추출법을 이용하여 토마토로부터 추출함에 있어서, 조용매로 스쿠알렌(squalene)을 사용하여 물이나 에탄올과 같은 용매가 배합되지 못하는 메이크업 화장료에도 적용이 가능하도록 친유성(oleophilicity)을 부여한 유용성 항산화 성분에 관한 것을 개시하였다.Looking at domestic and foreign patent applications regarding the extraction method of lycopene in tomato, Korean Patent Application Publication No. 2006-0070846 discloses a supercritical extraction method of lycopene showing an excellent antioxidant effect by inhibiting the generation of free radicals in the process of oxygen respiration metabolism In extracting from tomato using the present invention, it discloses a useful oil antioxidant component that gives oleophilicity to be applied to makeup cosmetics in which solvent such as water or ethanol cannot be mixed using squalene as a co-solvent. It was.
또한, 일본 특개평 10-276707호에는 펙틴분해효소 처리를 하고 여과기(0.3-0.7mm)로 고액분리를 하여 얻은 미세 플럽(plup)를 분리막(10um이하)로 여과하여 얻은 농축 플럽을 회수하여 식재료로 사용하는 것에 관한 저점도인 고함량 리코펜을 식재료 제조방법을 기재하고 있다. In addition, Japanese Patent Application Laid-Open No. 10-276707 discloses a concentrated flop obtained by filtering a fine flop obtained by pectinase treatment and solid-liquid separation with a filter (0.3-0.7 mm) using a separation membrane (10 μm or less). It describes a low-viscosity high content of lycopene for use as a foodstuff manufacturing method.
또한, 미국 공개특허번호 2005/0153038은 추출토마토를 가열 농축시키고 물-포화 에틸아세테이트로 추출하는 토마토 전체로부터 리코펜 추출물의 제조방법에 관한 것이다.US Patent No. 2005/0153038 also relates to a method for preparing lycopene extract from tomatoes, which are concentrated by heating the extracted tomato and extracted with water-saturated ethyl acetate.
또한, 국내 특허1991-0006937은 토마토를 파쇄, 착즙하여 얻은 토마토 처리물을 살균하여 냉각한 후, 예비 배양해 둔 락토바실러스 불가리커스를 가하여 젖산 발효를 행하는 것을 특징으로 하는 젖산발효음료의 제조방법에 관한 것이다.In addition, the domestic patent 1991-0006937 sterilizes the tomato processing material obtained by crushing and juice the tomato, sterilized and cooled, and then the lactic acid fermentation beverage manufacturing method characterized in that the lactic acid fermentation is performed by adding the pre-cultured Lactobacillus Bulgarius. It is about.
또한, 국내 공개특허번호 10-1998-0053132은 자색고구마 색소농축액에 말토텍스트린 등을 첨가하고 분무건조하는 공정으로 이루어진 자색고구마 색소분말의 제조방법에 관해 기재하고 있습니다.In addition, Korean Laid-open Patent No. 10-1998-0053132 describes a method for producing a purple sweet potato pigment powder, which is a process of adding malto textrin to a purple sweet potato pigment concentrate and spray drying.
이렇듯, 기존의 문헌들은 유기용매에 의해 화학적 처리방법을 사용하거나, 물 또는 오일에 의한 물리적 처리방법, 그리고 락토바실러스 불가리커스 유산균에 의한 미생물학적 방법 등에 관해 기재하고 있을 뿐, 유산균을 이용해 고함량의 리코펜을 함유하는 방법에 관해 기재하고 있지 않으며, 또한 동결 건조시 말토텍스트린보다 성능이 좋은 안정화 보조제를 첨가함으로써 리코펜의 함량을 안정적으로 유지하는 방법에 관해서도 기재하고 있지도 않았다.As such, the existing literatures describe chemical treatment with organic solvents, physical treatment with water or oil, and microbiological methods with Lactobacillus vulgaris lactobacillus. It does not describe a method of containing lycopene, nor does it describe a method of stably maintaining the content of lycopene by adding a stabilizing aid that performs better than maltotextrin during freeze drying.
이에 본 발명의 목적은 안정적으로 리코펜을 다량 함유하면서, 섭취자의 생리적 기능의 활성이 향상되도록, 물리적 처리로 얻은 토마토 과육 펄프를 농축하고, 열처리한 후 유산균을 이용하여 발효처리하고, 이를 안정화 보조제 첨가와 함께 동결-분말화한 토마토의 가공방법 및 그의 제품을 제공하는 것에 있다.Therefore, an object of the present invention is to stably contain a large amount of lycopene, so as to improve the activity of the physiological function of the intake, concentrating the tomato pulp obtained by physical treatment, heat treatment and fermentation using lactic acid bacteria, and adding a stabilizing aid Together with a method of processing a freeze-powdered tomato and a product thereof.
상기와 같은 목적을 달성하기 위하여, 본 발명은 완숙한 토마토를 구입하거나 미숙한 토마토를 일정기간 보관하여 완숙시키는 제1단계; In order to achieve the above object, the present invention is to purchase a ripe tomato or to store the immature tomato for a certain period of time to complete;
토마토를 세척하고, 표면의 수분을 제거하도록 탈수하는 제2단계;A second step of washing the tomatoes and dehydrating to remove water from the surface;
토마토 표면의 상처 또는 물러진 곳을 제거하여 선과하는 제3단계;A third step of removing the wounds or dents on the surface of the tomato;
과피를 벗기는 탈피하는 제4단계;A fourth step of peeling off the skin;
과육이 과피 또는 씨와 분리되도록 분쇄하고, 과육 펄프를 이들과 분리하는 제5단계;A fifth step of grinding the pulp to separate from the rind or seed, and separating the pulp from the pulp;
과육으로만 형성된 주스 과육펄프로 분리하고, 과피 또는 씨 등을 케이크로 분리하는 제6단계;A sixth step of separating the juice pulp formed only from the pulp and separating the rind or seeds into a cake;
이후 공정을 위해 주스 과육펄프를 농축화하고, 살균하는 제7단계;A seventh step of concentrating and sterilizing the juice pulp for the subsequent process;
상기 주스 과육펄프를 유산균으로 발효시키는 제8단계; 및An eighth step of fermenting the juice pulp with lactic acid bacteria; And
이후 고형물을 회수하는 제9단계; 및A ninth step of recovering the solids thereafter; And
상기 발효된 토마토주스 과육펄프에 안정화 보조제를 첨가하고, 동결건조 분 말화하는 제10단계를 포함하는 것을 특징으로 합니다.Adding a stabilizing aid to the fermented tomato juice pulp, characterized in that it comprises a tenth step of lyophilized powder.
하기에서 이에 대해 구체적으로 살펴보도록 하겠다.This will be described in detail below.
본 발명의 유산균을 이용한 발효토마토의 제조방법의 제1단계는 완숙 토마토를 구입하거나, 미완숙 토마토를 실내 보관용기에 담아 완숙시키는 것이다. The first step of the method for producing a fermented tomato using the lactic acid bacteria of the present invention is to purchase ripe tomatoes or to put the unripe tomatoes into an indoor storage container to ripen.
토마토는 익을수록 더욱 붉은 색을 띠는데 붉은 색이 짙을수록 리코펜(lycopene)과 베타카로틴(beta-caroteine) 성분이 풍부해 진다. 덜 익은 상태의 파란색 토마토를 수확해서 숙성하는 것보다는 완전히 붉게 성숙된 뒤 수확한 것에 리코펜이 더 풍부하다. 초록색이 도는 덜 익은 것을 사서 15-18℃의 서늘한 장소에 보관하여 서서히 익혀 본 발명에 이용할 수 있다.Tomatoes become more red as they ripen, and the deeper the red, the richer the lycopene and beta-caroteine. Lycopene is more abundant in harvests that are fully red mature and harvested rather than harvested and ripened blue tomatoes. You can buy green less ripe and store it in a cool place at 15-18 ℃ to cook slowly and use it in the present invention.
또한, 본 발명의 제2단계에서는 흐르는 물에 토마토의 표면을 세척하여 이물질을 제거하고, 표면의 수분을 제거하는 탈수 과정이다.In addition, in the second step of the present invention is a dehydration process to remove the foreign matter by washing the surface of the tomato in running water, to remove the moisture on the surface.
또한, 본 발명의 제3단계에서는 표면에 상처가 난 곳은 칼로 도려내고, 물러진 곳도 칼로 도려냄으로써, 신선한 토마토 과육만을 이용할 수 있도록 처리하는 과정이다.In addition, in the third step of the present invention, the wound on the surface is cut out with a knife, and the receded part is cut out with a knife to process only the fresh tomato pulp.
본 발명의 제4단계에서는 토마토의 껍질을 제거하는 과정으로서, 대량 생산을 위해 뜨거운 스팀에서 3 내지 4분간 처리하여 과피가 과육으로부터 물리적으로 이탈되어 벗겨지도록 유도하는 방법이 이용될 수 있다.In the fourth step of the present invention, as a process of removing the skin of the tomato, a method of inducing the peel to peel off physically from the flesh by treating for 3 to 4 minutes in hot steam for mass production.
본 발명의 제5단계에서는 압착식 과육 분쇄기로 과육이 과피, 씨, 단단한 부분과 분리되도록 분쇄하고, 이후 여과망을 이용하여 여과망을 통과하는 과육을 통과하지 못하는 과피, 씨, 단단한 부위와 분리하는 과정이다. 여기서 여과망은 과 육펄프을 분리할 수 있는 것이면 제한되지 않으나, 바람직하게 망눈의 크기가 대략 0.8 내지 1.1mm가 적당하다.In the fifth step of the present invention, the pulp is pulverized so that the pulp is separated from the rind, the seed and the hard part by a pulverized pulp mill, and then separated from the rind, the seed, and the hard part which do not pass the pulp passing through the filter net using the filter net. to be. The filter network is not limited as long as it can separate the pulp, but preferably about 0.8 to 1.1 mm in size.
또한, 본 발명의 제6단계는 상기 제5단계에서 분리된, 과육으로만 형성된 주스과육펄프와, 과피, 씨 및 단단한 분위로 이루어진 케이크를 분리하는 과정이다.In addition, the sixth step of the present invention is a process for separating the juice pulp formed only of the pulp and the cake consisting of the rind, the seed and the hard portion separated in the fifth step.
본 발명의 제7단계는 상기 살균된 주스과육 펄프를 농축화하고, 약 100℃에서 15 내지 45분 열처리 살균하는 과정이다. 농축화는 목적에 따라 막분리, 원심분리, 또는 감압농축 공정으로 주스를 농축할 수 있다.The seventh step of the present invention is a process of concentrating the sterilized juice pulp pulp and heat treatment sterilization for 15 to 45 minutes at about 100 ℃. Concentration can concentrate the juice by membrane separation, centrifugation, or vacuum concentration process depending on the purpose.
일반적으로, 신선한 토마토에 비해 가공(농축된) 토마토의 리코펜 함량이 풍부하다. 하기 표 1에서 알 수 있듯이 신선한 붉은 토마토 100g에서는 3.1-3.7mg수준이고, 주스로 가공한 경우에는 7.83mg, 주스를 농축한 페이스트에서는 30.0 mg이다. In general, lycopene content of processed (concentrated) tomatoes is richer than fresh tomatoes. As can be seen in Table 1 below, 100 g of fresh red tomato is 3.1-3.7 mg level, 7.83 mg when processed into juice, and 30.0 mg in concentrated juice paste.
따라서, 상기의 주스과육펄프의 농축화 과정은 열처리가 포함된 공정으로 흡수율이 좋은 개선된 시스형 리코펜이 고함량으로 농축되어 수득할 수 있게 된다.Therefore, the concentration of the juice pulp pulp can be obtained by a high content of improved cis-type lycopene with good absorption in the process including heat treatment.
또한, 본 발명의 제8단계는 유산균을 이용하여 상기 토마토주스를 발효시키는 과정이다.In addition, the eighth step of the present invention is a process of fermenting the tomato juice using lactic acid bacteria.
본 발명에 사용되는 유산균이 특별히 제한되는 것은 아니나, 락토바실러스.아시도필러스(L.acidophillus), 락토바실러스 .프란타늄(L. plantarum), 락토바실러스.카세이(L.casei), 락토바실러스.불가리스(L.bulgaris), 스트렙토코커스.써모필러스(St.thermophillus), 비피도박테리움 브레이브(Bifiidobacterium breve), 비피도박테리움 롱검(Bifiidobacterium longum), 비피도박테리움 인판티스(Bifiidobacterium infantis), 및 로코노스톡 메센트로이드(Leuconostoc mesentroide)를 예로 들 수 있다.The lactobacillus used in the present invention is not particularly limited, but Lactobacillus. L. acidophillus, Lactobacillus .Frantanum (L. plantarum), Lactobacillus. L.bulgaris, Streptococcus.St.thermophillus, Bifiidobacterium breve, Bifiidobacterium longum, Bifiidobacterium infantis, And leuconostoc mesentroide.
또한, 유산균의 순수 배양은 MRS 배지를 이용하여, 보관중인 균주 1백금이를 채취하여 MRS 배양액(Broth)가 든 100ml 캡 튜브(cap tube)에 접종하여 약 35 내지 37℃에서 하루밤 정치배양하여 활성화시키고, 50~100ml MRS 배양액이 들어 있는 밀봉한 삼각플라스크에서 종균으로 배양하여 본 배양에 사용할 수 있다.In addition, the pure culture of lactic acid bacteria is activated by incubating overnight at about 35 to 37 ° C by inoculating 100 ml of the stored strain, inoculated into 100 ml cap tube containing MRS broth using MRS medium. Then, it can be used for the main culture by culturing as a seed in a sealed Erlenmeyer flask containing 50 ~ 100ml MRS culture.
또한, 삼각플라스크에서 토마토를 발효하는 경우, 토마토 농축액 시료 100ml에서 500ml까지는 삼각플라스크 배양기를 이용하고, 유산균을 접종한 후 입구부분은 공기가 유입되지 않도록 밀폐하고, 배양하는 동안 빛에 노출되지 않도록 조치하였으며, 쉐이킹 인큐베이터(Shaking incubator)를 이용하여 35-37℃, 120rpm에서 배양한다. In addition, when fermenting tomatoes in an Erlenmeyer flask, use an Erlenmeyer flask incubator from 100 ml to 500 ml of the tomato concentrate sample, and after inoculating the lactic acid bacteria, seal the inlet to prevent air from entering and prevent exposure to light during the incubation. And, using a shaking incubator (Shaking incubator) is incubated at 35-37 ℃, 120rpm.
5L 소형발효기(Jar fermentor)를 이용하는 경우, 토마토 농축액을 유산균으로 발효하기 위하여 총 부피를 4 L로 조정하여 살균하고, 유산균을 접종하고 내부에 공기가 유입되지 않도록 하여 35-37℃, 200rpm에서 배양한다. In case of using 5L Jar fermentor, sterilize by adjusting total volume to 4L to ferment tomato concentrate to lactic acid bacteria, inoculate lactic acid bacteria and incubate at 200rpm to prevent air from entering do.
본 발명의 제9단계는 상기 고형물을 회수하는 과정이다.The ninth step of the present invention is a process of recovering the solids.
마지막으로, 제10단계의 분말화에서 유산균 발효된 토마토를 냉동건조하는 방법을 이용할 수 있다. 건조시료를 얻기 위한 동결건조(FD) 방법은 가열건조 방법보다 열에 약한 시료나 유익균의 생존을 위하여 유용하게 활용할 수 있다. Finally, a method of freeze drying the lactic acid bacteria fermented tomato in the powdering of the tenth step may be used. Freeze-drying (FD) method for obtaining a dry sample may be useful for the survival of heat-sensitive samples or beneficial bacteria than the heat drying method.
특히 제10단계의 동결 분말 건조 과정에는 안정화 보조제가 첨가된다. 일반적으로 동결과정에 첨가제로는 말토덱스트린이 사용되나, 발효토마토의 리코펜 성분의 안정화 향상 개선을 위하여는 비타민C, 비타민E, 사이크로덱스트린으로 구성된 안정화 조성물을 사용하는 것이 바람직하다. 상기 안정화 조성물 구성비는 당업자라면 적당하게 조정할 수 있으나, 토마토 발효 후 얻은 케이크(고형물 함량 10%) 100중량에 대하여 비타민 C는 약 0.05 내지 0.2중량, 비타민 E는 약 0.01 내지 0.03중량, 사이크로덱스트린은 약 2 내지 4중량이 바람직하며, 특히 비타민 C는 0.1중량, 비타민 E는 0.02중량, 사이크로덱스트린은 3중량이 바람직하다.In particular, in the freeze powder drying process of the tenth step, a stabilizing aid is added. In general, maltodextrin is used as an additive in the freezing process, but in order to improve the stabilization of the lycopene component of the fermented tomato, it is preferable to use a stabilizing composition composed of vitamin C, vitamin E, and cyclodextrin. The composition of the stabilizing composition may be appropriately adjusted by those skilled in the art, but about 0.05 to 0.2 weight of vitamin C, about 0.01 to 0.03 weight of vitamin E, and cyclodextrin, based on 100 weight of cake (solid content 10%) obtained after tomato fermentation About 2 to 4 weights are preferred, in particular, vitamin C is preferably 0.1 weight, vitamin E is 0.02 weight, and cyclodextrin is 3 weight.
본 발명은 압착식 물리적 처리로 얻은 토마토 과육 펄프를 농축하고, 열처리한 후 유산균을 이용하여 발효처리하고, 이를 안정화 보조제 첨가와 함께 동결-분말화함으로써, 가공된 발효 토마토가 기능성 성분인 리코펜을 고함량으로 안정적으로 함유하여, 그 가공된 발효 토마토를 섭취한 자의 체내 생리활성 기능을 향상시켜줄 수 있다. 상품가치가 저하된 토마토를 그대로 식품으로 이용하기에는 부적절하지만, 유산균을 이용한 발효 가공을 함으로써 토마토 고유취의 개선과 기능성분인 리코펜의 함량을 높이고, 안정화 기술을 향상시킴으로써 기능성 제품으로의 활용성을 높여 1차 생산업체 및 2차 가공업체와 건강식품산업으로 연계함으로써 유용한 식품원재료 및 기능성 원료로의 생산이 가능하다.The present invention concentrates the tomato pulp obtained by the compression physical treatment, heat treatment and fermentation using lactic acid bacteria, and freeze-powdered it with the addition of a stabilizing aid, so that the processed fermented tomato is a functional ingredient lycopene By stably contained in the content, it can improve the physiological activity function of the body ingested the processed fermented tomato. Although it is inappropriate to use tomatoes with reduced product value as foods, fermentation processing using lactic acid bacteria improves the intrinsic odor of tomatoes, increases the content of lycopene as a functional ingredient, and improves the utilization of functional products by improving stabilization technology. By linking primary producers and secondary processors with the health food industry, it is possible to produce useful food raw materials and functional raw materials.
이하 도면을 참조하여 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 본 명세서에 기재된 도면 및 실시예에 도시된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 변형예들이 있을 수 있음을 이해하여야 한다.Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings. Configurations shown in the drawings and embodiments described herein are only one of the most preferred embodiments of the present invention and do not represent all of the technical idea of the present invention, various modifications that can be substituted for them at the time of the present application It should be understood that there may be
실시예Example 1. One. 리코펜Lycopene 함량 및 안정화 실험 Content and Stabilization Experiment
(1) 토마토 발효 및 분말화 과정(1) Tomato fermentation and powdering process
토마토를 수세하고 탈수하여 상처난 부위와 꼭지를 제거하고, 주스착즙기 (Juice pulper)를 이용하여 과육을 분쇄하여 케이크(cake)를 분리하고, 토마토 주스 과육를 얻었다. 토마토 주스 과육을 원심분리기기로 농축하여 토마토 과육 농축물을 얻었다. 토마토 과육 농축물의 살균은 100℃에서 15 내지 30분간 열처리하였고, 발효시에는 비피도박테리움 브레이브(Bifidobacterium breve)를 종균으로 접종하여 발효기(5L Jar Fermentor)에서 35℃에서 발효시켰다. 이후 발효된 토마토 과육을 포함한 시료를 동결건조기를 이용하여 -50℃이하에서 동결건조하여 분말화하였다.Washing and dehydrating the tomato to remove the wound and the tap, and using a juice pulper pulverized the flesh to separate the cake (cake), to obtain a tomato juice pulp. The tomato juice pulp was concentrated by a centrifugal separator to obtain a tomato pulp concentrate. Sterilization of the tomato pulp concentrate was heat-treated at 100 ° C. for 15 to 30 minutes, and during fermentation, Bifidobacterium breve was inoculated with the seed and fermented at 35 ° C. in a 5 L Jar Fermentor. After that, the sample containing the fermented tomato pulp was lyophilized at -50 ° C. or below using a freeze dryer to be powdered.
(2) 리코펜 함량 분석 방법(2) Lycopene content analysis method
리코펜 분석은 분광 광도계(Spectrophotometer) 측정법으로 측정하였다. 균질화한 시료 2g에 6% 피로갈로를 에탄올 10mL에 첨가하고, 질소가스로 충진한 후, 60% KOH 용액 8mL을 첨가한 후 질소가스로 재충진하여 냉각관을 연결하였다. 이를 70℃ 수욕상에서 50분간 검화시킨 후 냉각시키고, 2% NaCl 용액을 이용하여 에탄올 농도를 30%로 조절하였다. BHT(0.01%)를 함유하고 있는 추출용매(헥산:아세톤:메탄올) 15mL을 첨가하여 3회 반복 추출하였으며, 추출액은 무수 MgSO4을 통하여 수분을 제거하고, 최종 50mL로 적용하였다. 0.22um 막 여과기(Sartorius, Goettingen, Germany)을 이용하여 여과하여 헥산층을 회수하여 원심분리하여 470nm 및 502nm에서 분광 광도계(Perkin Elmer UV/VIS Lambd35)을 이용하여 흡광도를 측정하여 OD측정값을 측정하여 표준시약 리코펜으로 표준곡선과 표준식에 의하여 계산하여 측정하였다. Lycopene analysis was measured by spectrophotometer measurement. To 2 g of the homogenized sample, 6% pyrogallo was added to 10 mL of ethanol, and filled with nitrogen gas. Then, 8 mL of 60% KOH solution was added and refilled with nitrogen gas to connect the cooling tube. This was saponified for 50 minutes in a 70 ° C. water bath, cooled, and the ethanol concentration was adjusted to 30% using 2% NaCl solution. 15 mL of extraction solvent (hexane: acetone: methanol) containing BHT (0.01%) was added thereto, followed by extraction three times. The extract was removed with anhydrous MgSO 4 and applied to the final 50 mL. The hexane layer was collected by filtration using a 0.22um membrane filter (Sartorius, Goettingen, Germany), centrifuged, and absorbance was measured using a spectrophotometer (Perkin Elmer UV / VIS Lambd35) at 470 nm and 502 nm. The standard reagent lycopene was calculated by the standard curve and the standard formula.
(3) 토마토의 발효 전후의 리코펜 함량 변화(3) Change of Lycopene Content Before and After Fermentation of Tomato
신선한 토마토 1kg를 수세하여 100℃에서 5분간 스팀처리하고, 토마토 과즙기로 가공 처리하여 케이크를 제거하고 얻은 토마토 주스 과육을 농축하여 얻은 농축액의 고형물 함량을 15~20%으로 조정하였다. 이후 100℃에서 30분간 열처리한 발효 전 시료와, 유산균 비피도박테리움 브레이브를 접종하여 2일간 발효하여 회수한 발효 후 시료를 각각 동결건조한 후 6개월간 냉장보관 후 측정한 리코펜의 함량은 하기 표 2와 같이 각각 건조중량 100g 당 각각 32.6 mg과 96.0 mg이었다.1 kg of fresh tomatoes were washed with water, steamed at 100 ° C. for 5 minutes, processed with a tomato juicer to remove cakes, and the solids content of the concentrate obtained by concentrating the obtained tomato juice pulp was adjusted to 15-20%. After incubation for 30 days and then inoculated with lactic acid bacteria Bifidobacterium brave heat-treated for 30 minutes at 100 ℃ after fermentation and recovery of the samples after fermentation and freeze-drying for 6 months, respectively, the content of lycopene is measured in Table 2 As 32.6 mg and 96.0 mg per 100 g dry weight, respectively.
발효토마토의 유산균 첨가에 의해 발효시에 형성된 대사산물 및 유산균 자체의 생존력을 높이기 위하여 동결건조를 실시하는 편이 효과적이다. 이에 발효 전 토마토 주스 농축액(비발효 토마토 : 열처리 100℃, 30분)과 발효 후 토마토 주스 농축액(발효 토마토: 비피도박테리움 브레이브에 의한 발효)의 동결건조시의 분말을 각각 용기에 넣고 불활성 가스로 충진하지 않은 상태로 6개월간 냉장에서 저장한 후의 4개월의 저장실험을 실시하여 리코펜의 상대적 함량을 관찰하여 표 3와 같은 결과를 얻었다.It is more effective to carry out lyophilization in order to increase the viability of the metabolite formed during fermentation and the lactic acid bacteria itself by the addition of lactic acid bacteria of fermented tomato. The fermented tomato juice concentrate (non-fermented tomato: heat treatment 100 ℃, 30 minutes) and the fermented tomato juice concentrate (fermented tomato: fermented by Bifidobacterium brave), respectively, into a container and put inert gas After four months of storage experiments after 6 months of storage in the refrigerated state, the relative contents of lycopene were observed to obtain the results shown in Table 3.
4개월간의 보관 중 리코펜의 함량을 측정하였을 때, 발효 토마토 동결건조 분말이 리코펜 함량이 상대적으로 안정적이었으며, 발효 토마토 동결분말에서 리코펜 함량이 상대적으로 높게 유지됨을 확인하였다.When the content of lycopene during storage for 4 months was measured, the lycopene content of the fermented tomato lyophilized powder was relatively stable, and the lycopene content was maintained relatively high in the fermented tomato freeze powder.
Storage condition: unfilled upper inert gas in the container, storage temperature: refrigeration temperature
(4) 동결 건조시 안정화 조성물 첨가에 의한 리코펜의 안정성 변화(4) Stability Change of Lycopene by Freeze-Drying Stabilizing Composition
동결 건조시의 발효 토마토 내의 항산화 물질인 리코펜의 안정성(stability)개선을 위해 첨가되는 보조제 조성물의 효과를 측정하기 위해 40℃, 질소가스 충전 상태의 가속 보관 조건에서 실험을 실시하였으며, 그 결과는 하기 표 4 및 도 1와 같다. In order to measure the effect of the adjuvant composition added to improve the stability of lycopene, an antioxidant substance in fermented tomato during freeze drying, experiments were conducted under accelerated storage conditions at 40 ° C. and nitrogen gas. Table 4 and FIG.
Composition composition type
비타민 E
사이크로덱스트린Vitamin c
Vitamin E
Cyclodextrin
테스트 Ⅱ의 조성물을 구성한 경우가 조성물을 첨가하지 않은 경우(대조군)나 일반적으로 사용하는 말토덱스트린을 첨가하는 경우(테스트 Ⅰ)보다 리코펜 함량의 감소가 상대적으로 적어 리코펜 안정화에 더욱 효과가 있음을 보여준다.It is shown that the composition of Test II is more effective in lycopene stabilization due to the relatively smaller decrease in lycopene content than when no composition is added (control) or when maltodextrin is commonly used (Test I). .
실시예Example 2. 생리활성 실험 2. Biological activity experiment
(1) 실험동물(1) experimental animals
5주령 ICR 수컷 마우스를 (주) 오리엔트 바이오에서 구입한 후, 일주일간 조명시간을 아침 7시부터 저녁 7시까지 12시간으로, 실내온도는 22~ 24℃로 조절된 동물실에 적응시킨 후 본 실험에 사용하였다. 사료는 AIN-76 사료를 제공하고 급수는 식수를 사용하였으며 사료와 급수는 제한하지 않았다.After purchasing 5-week-old ICR male mice from Orient Bio Co., Ltd., the lighting time was adjusted to 12 hours from 7 am to 7 pm and the room temperature was adjusted to 22 ~ 24 ° C. It was used for the experiment. Feed provided AIN-76 feed and drinking water was used, but feed and water supply were not limited.
(2) 실험동물의 처치(2) Treatment of experimental animals
25마리의 마우스를 하기 표 5에 제시한 것과 같이, NC(대조군), EC 처리군(에탄올 단독 투여군), 비타민 C 처리군(에탄올과 비타민 C 투여군), EC 처리군에서 발효 토마토 동결건조분말을 1주일간 섭취시킨 군(FTE)으로 나누고, 온도 (22 ~ 24℃), 습도 (50%), 12시간 사이클로 반복되는 명암 조건에서 사육하면서 실험하였다. 각 에탄올, 비타민 C, 토마토 동결건조분말을 일주일간 경구투여 하였다.As shown in Table 5, 25 mice were fermented tomato lyophilized powder from NC (control), EC treated group (ethanol-only group), vitamin C treated group (ethanol and vitamin C-treated group), EC treated group. Divided into groups (FTE) ingested for 1 week, the experiment was carried out in a dark and dark condition repeated in temperature (22 ~ 24 ℃), humidity (50%), 12 hours cycle. Each ethanol, vitamin C, tomato lyophilized powder was orally administered for a week.
(3) 실험동물의 체중 및 조직 무게 측정 (3) Measurement of body weight and tissue weight of laboratory animals
실험 시작 전과 실험 종료시점에서 체중을 측정하여 체중증가량(weight gain)을 계산하였고, 최종 경구투여 12시간 후에 각 군의 마우스를 해부하여 간, 신장, 비장, 정소, 신장지방, 정소지방의 양을 측정하였다. The weight gain was calculated by measuring the weight before and after the experiment and at 12 hours after the final oral administration, the mice in each group were dissected to determine the amount of liver, kidney, spleen, testis, kidney fat and testis fat. Measured.
실험 결과는 하기의 표 6와 같으면, 상호간의 유의적인 차이를 보이지는 않았지만, 간의 경우 FTE 군이 상대적으로 회복이 좋았으며, 장기간 섭취시킨다면 정상회복에 도움이 될 것으로 보인다.Experimental results are shown in Table 6 below, but did not show a significant difference between each other, in the case of liver FTE group was relatively good recovery, long-term ingestion seems to help normal recovery.
Treatment group
Weight
(4) In vivo 항산화 활성 평가(4) In In vivo antioxidant activity assessment
간조직은 PBS (pH 7.4)로 균질화하여 항산화 활성 평가에 이용하였다.Liver tissue was homogenized with PBS (pH 7.4) and used for the evaluation of antioxidant activity.
1) 카탈라아제(CAT) 분석1) Catalase (CAT) Analysis
카탈라아제(Catalase) 활성은 에이비(Aebi)사의 스펙트로포토메트릭 방법으로 분석하였다. 96 웰 플레이트(well plate)를 준비하고, 조직액 10㎕에 20mM H2O2용액 290㎕를 첨가하여 마이크로플레이드 리더의 키네틱 방법을 이용하여 3분간 240nm에서 흡광도의 변화를 측정하였다. 카탈라아제 효소의 활성은 U/mg 단백질로 환산하였다.Catalase activity was analyzed by Spectrophotometric method of Aebi. A 96 well plate was prepared, and 290 μl of 20 mM H 2 O 2 solution was added to 10 μl of the tissue solution, and the change in absorbance was measured at 240 nm for 3 minutes using the kinetic method of the microplate reader. The activity of the catalase enzyme was converted to U / mg protein.
2) 글루타치온 전환효소(Glutathione-s-transferase:GST) 분석2) Glutathione-s-transferase (GST) analysis
글루타치온 전환효소 활성은 헤비그(Habig)사의 스펙트로포토메트릭 방법으로 분석하였다. 96 웰 플레이트(well plate)를 준비하고, Dulbecco사의 포스페이트 버퍼된 식염수 196㎕와 200mM 글루타치온 2㎕, 100mM CDNB 용액 2㎕을 혼합한 기질액을 준비하였다. 조직액 20㎕에 기질액 180㎕를 첨가하여 5분간 340nm에서 흡광도의 변화를 측정하였다. 글루타치온 전환효소 효소활성은 U/mg 단백질로 계산하였다.Glutathione convertase activity was analyzed by spectrophotometric method of Habig. A 96-well plate was prepared, and a substrate solution containing 196 μl of Dulbecco's phosphate buffered saline, 2 μl of 200 mM glutathione, and 2 μl of 100 mM CDNB solution was prepared. 180 μl of substrate solution was added to 20 μl of the tissue solution, and the change in absorbance was measured at 340 nm for 5 minutes. Glutathione convertase enzyme activity was calculated by U / mg protein.
3) 글루타치온 과산화효소 (glutahione peroxidase"GPx) 분석3) Glutathione peroxidase (GPx) assay
글루타치온 과산화효소 활성은 톰슨(Thomson)사의 스펙트로메트릭 방법으로 분석하였다. 96 웰 플레이트(well plate)를 준비하고, 조직액 10㎕에 3.5 mM 글루타치온 120㎕, 2.5 mM NADPH 20㎕, 0.5 U 글루타치온 환원효소 20㎕를 넣어 잘 혼합한 후, 30 mM 터트-부틸 하이드로퍼옥사이드 20㎕를 첨가하여 반응을 유도하고 5분간 340nm에서 흡광도의 변화를 측정하였다. 글루타치온 과산화효소활성은 U/mg 단백질로 계산하였다.Glutathione peroxidase activity was analyzed by Thomson's spectrometric method. A 96 well plate was prepared, and 10 µl of the tissue solution was mixed with 120 µl of 3.5 mM glutathione, 20 µl of 2.5 mM NADPH and 20 µl of 0.5 U glutathione reductase, followed by 30 mM tert-
4) 글루타치온 환원효소 (gluathione reductase:GR) 분석4) Glutathione reductase (GR) analysis
글루타치온 환원효소 활성은 스펙트로메트릭 방법으로 분석하였다. 96 웰 플레이트(well plate)를 준비하고, 조직액 20㎕에 100 mM 포타슘 포스페이트 버퍼 (pH 7.0) 30uL, 2mM 산화된 글루타치온 100uL, 3mM DTNB 50uL를 넣어 잘 혼합한 후, 2mM NADPH 10uL를 첨가하여 반응을 유도하고 5분간 412nm에서 GR 효소활성을 측정하였다. 글루타치온 환원효소 효소활성은 U/mg 단백질로 계산하였다.Glutathione reductase activity was analyzed by spectrometric method. Prepare a 96 well plate, add 30 μL of 100 mM potassium phosphate buffer (pH 7.0), 100 μL of 2 mM oxidized glutathione, and 50 μL of 3 mM DTNB to 20 μl of the tissue solution, and mix well. Then, add 10 μL of 2 mM NADPH to react. Induction and GR enzyme activity was measured at 412 nm for 5 minutes. Glutathione reductase enzyme activity was calculated as U / mg protein.
5) 환원 글루타치온 (reduced glutathion:GSH) 분석5) Reduced glutathion (GSH) analysis
글루타치온 양은 그리피츠(Griffith)사의 스펙트로메트릭 방법으로 분석하였다. 96 웰 플레이트(well plate)를 준비하고, 100mM 포타슘 포스페이트 버퍼 (pH 7.0) 7.54mL, 6 유닛 글루타치온 환원효소 228㎕, 3mM DTNB 228㎕를 혼합하여 기질액을 만들었다. 조직액 10㎕에 준비한 기질액 150㎕를 잘 혼합한 후 50mM NADPH 50㎕를 첨가하여 반응을 유도하고 5분간 412nm에서 흡광도의 변화를 측정하였다. 조직내의 GSH량은 GSH 표준곡선을 이용하여 계산하여 umoles/mg 단백질로 나타내었다.Glutathione amounts were analyzed by Griffith's spectrometric method. A 96 well plate was prepared, and a substrate solution was prepared by mixing 7.54 mL of 100 mM potassium phosphate buffer (pH 7.0), 228 μl of 6 unit glutathione reductase, and 228 μl of 3 mM DTNB. After mixing 150 μl of the prepared substrate solution to 10 μl of the tissue solution, 50 μl of 50 mM NADPH was added to induce the reaction, and the change in absorbance was measured at 412 nm for 5 minutes. The amount of GSH in tissues was calculated using the GSH standard curve and expressed as umoles / mg protein.
(5) 실험 결과(5) experimental results
마우스에 알코올로 간소상을 유발시키고, 본 발명의 발효 토마토를 마우스에 섭취시킨 후, 조직을 적출하여 마우스 간의 건강 지표 변화를 측정하였다. The mice were inoculated with a small phase with alcohol, the fermented tomato of the present invention was ingested into the mice, and tissues were extracted to measure changes in health indicators between the mice.
간의 건강기능지표인 CAT(카탈라아제)(도 3), GST(글루타치온-S-트렌스퍼라아제)(도 4), GPx(글루타치온-퍼옥시다아제)(도 5), GHS(글루타치온)(도 6), GR(글루타치온 환원효소)(도 7)의 활성이 증진되는 것을 확인하였다. CAT (catalase) (FIG. 3), GST (glutathione-S-transferase) (FIG. 4), GPx (glutathione-peroxidase) (FIG. 5), GHS (glutathione) (FIG. 6), which are liver health indicators It was confirmed that the activity of GR (glutathione reductase) (FIG. 7) was enhanced.
도 1은 보조제 첨가에 의한 가속보관 조건에서 리코펜 함량 변화를 보여주는 그래프이다.Figure 1 is a graph showing the change in lycopene content under accelerated storage conditions by the addition of the adjuvant.
도 2은 테스트 B의 질소처리시의 가속보관 조건에서 리코펜 함량 변화를 보여주는 그래프이다.Figure 2 is a graph showing the change in lycopene content under accelerated storage conditions during nitrogen treatment of Test B.
도 3는 가공토마토를 섭취한 마우스 간 실험에서 CAT(카탈라아제)의 활성 변화를 보여주는 그래프이다.Figure 3 is a graph showing the change in activity of CAT (catalase) in mouse liver experiments ingested processed tomatoes.
도 4는 가공토마토를 섭취한 마우스 간 실험에서 GST(글루타치온-S-트랜스퍼라아제)의 활성 변화를 보여주는 그래프이다.Figure 4 is a graph showing the change in activity of GST (glutathione-S-transferase) in mouse liver experiments ingested processed tomato.
도 5는 가공토마토를 섭취한 마우스 간 실험에서 GPx(글루타치온 퍼옥시다아제)의 활성 변화를 보여주는 그래프이다.5 is a graph showing the change in activity of GPx (glutathione peroxidase) in mouse liver experiments ingested processed tomatoes.
도 6는 가공토마토를 섭취한 마우스 간 실험에서 GSH(감소된 글루타치온)의 활성 변화를 보여주는 그래프이다.Figure 6 is a graph showing the change in activity of GSH (reduced glutathione) in mouse liver experiments ingested processed tomatoes.
도 7는 가공토마토를 섭취한 마우스 간 실험에서 GR(글루타치온 환원효소)의 활성 변화를 보여주는 그래프이다.Figure 7 is a graph showing the change in the activity of GR (glutathione reductase) in mouse liver experiments ingested processed tomato.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090109126A KR101138783B1 (en) | 2009-11-12 | 2009-11-12 | Process of fermentated tomato using lactic acid bacteria and its product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090109126A KR101138783B1 (en) | 2009-11-12 | 2009-11-12 | Process of fermentated tomato using lactic acid bacteria and its product |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110052185A true KR20110052185A (en) | 2011-05-18 |
KR101138783B1 KR101138783B1 (en) | 2012-05-14 |
Family
ID=44362341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090109126A KR101138783B1 (en) | 2009-11-12 | 2009-11-12 | Process of fermentated tomato using lactic acid bacteria and its product |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101138783B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101316187B1 (en) * | 2011-09-27 | 2013-10-08 | 한국폴리텍특성화대학 산학협력단 | Processing method of tomato cake and its functional product |
KR20180117741A (en) * | 2017-04-19 | 2018-10-30 | 사단법인 장수식품클러스터사업단 | A method peeling tomato and tomato peeled by using the same |
KR102065584B1 (en) * | 2018-12-19 | 2020-01-13 | 재단법인 발효미생물산업진흥원 | Method for producing tomato fermented liquid with enhanced antioxidant and anti-obesity activity using Lactobacillus plantarum SRCM102223 strain |
CN111096403A (en) * | 2019-12-26 | 2020-05-05 | 新疆冠农果茸股份有限公司 | Preparation method of nutritional type compound lactobacillus fermented tomato juice |
CN112535315A (en) * | 2020-11-19 | 2021-03-23 | 河南中烟工业有限责任公司 | Preparation method of tomato tobacco flavor |
CN112662581A (en) * | 2020-12-10 | 2021-04-16 | 天津科技大学 | Lactobacillus acidophilus producing extracellular polysaccharide with anti-tumor, blood sugar reducing and blood fat reducing activities and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102421434B1 (en) * | 2017-08-31 | 2022-07-15 | 주식회사 유나이티드엑티브 | Fermented vegetable oil with improved oxidation stability and emulsificatin and preparation thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990046099A (en) * | 1999-03-20 | 1999-06-25 | 민병헌 | a tomato drink devise |
JP2006076925A (en) * | 2004-09-09 | 2006-03-23 | Toyo Shinyaku:Kk | Fermented material obtained from tomato |
-
2009
- 2009-11-12 KR KR1020090109126A patent/KR101138783B1/en not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101316187B1 (en) * | 2011-09-27 | 2013-10-08 | 한국폴리텍특성화대학 산학협력단 | Processing method of tomato cake and its functional product |
KR20180117741A (en) * | 2017-04-19 | 2018-10-30 | 사단법인 장수식품클러스터사업단 | A method peeling tomato and tomato peeled by using the same |
KR102065584B1 (en) * | 2018-12-19 | 2020-01-13 | 재단법인 발효미생물산업진흥원 | Method for producing tomato fermented liquid with enhanced antioxidant and anti-obesity activity using Lactobacillus plantarum SRCM102223 strain |
CN111096403A (en) * | 2019-12-26 | 2020-05-05 | 新疆冠农果茸股份有限公司 | Preparation method of nutritional type compound lactobacillus fermented tomato juice |
CN112535315A (en) * | 2020-11-19 | 2021-03-23 | 河南中烟工业有限责任公司 | Preparation method of tomato tobacco flavor |
CN112662581A (en) * | 2020-12-10 | 2021-04-16 | 天津科技大学 | Lactobacillus acidophilus producing extracellular polysaccharide with anti-tumor, blood sugar reducing and blood fat reducing activities and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101138783B1 (en) | 2012-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Filannino et al. | Exploitation of the health-promoting and sensory properties of organic pomegranate (Punica granatum L.) juice through lactic acid fermentation | |
KR100661032B1 (en) | Composition for Improving Liver Function, Reduction of Serum Ethanol Level, and Antioxidation | |
KR101138783B1 (en) | Process of fermentated tomato using lactic acid bacteria and its product | |
JP5563550B2 (en) | Antioxidants and antioxidant beverages | |
CN112244286A (en) | Calcium fruit powder and preparation method thereof | |
KR101064938B1 (en) | Preparetion of fermentated tomato using lactic acid bacteria | |
KR102044602B1 (en) | Preparation method for soybean-fermented composition having enhanced GABA, Conjugated linoleic acid and Aglycone isoflavones, combined probiotics for its fermentation and functional food of anti-diabetic and anti-obesity effects containing the soybean-fermented composition | |
JP2004073050A (en) | Method for producing fermented plant and lactic fermentation product | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
KR101984400B1 (en) | Process for producing antioxidant and anti-fatigue efficacy of mulberry vinegar | |
KR102127254B1 (en) | Cosmetic composition for skin whitening and moisturing comprising natural extracts | |
JP7385387B2 (en) | Method for producing gallic acid, method for producing fermented tea products, lactic acid bacteria, lactic acid bacteria compositions, fermented tea products, and food and drink products | |
KR101969708B1 (en) | Powder makgeolli composition containing DIY kit type lactic acid bacterium, method of preparing the composition, and makgeolli | |
KR102510719B1 (en) | Manufacturing method for seasoning sauce for ribs using sarcodon aspratus and seasoning sauce for ribs manufactured by the same | |
WO2020073437A1 (en) | Extract for preventing oxidation, delaying aging, and nourishing heart and cerebral vessels, and preparation method therefor | |
CN108703289A (en) | Using spirulina and sea buckthorn juice as the probiotics drink and preparation method of raw material | |
KR101713176B1 (en) | Fermented medicinal-herb composition having antioxidation activity and and method for preparing thereof | |
KR102094084B1 (en) | Aged and complex-fermented mountain-cultivated ginseng having increased ginsenosides of human body absorption type and omega-6 fatty acid, and preparation method thereof | |
KR102070613B1 (en) | Fermented products using dendropanax morbifera and sweet potatoes, their preparation method, and functional products using the same | |
KR100945670B1 (en) | Composition of healthy food containing fermented soybean powder | |
KR20210123691A (en) | Chicken radish seasoning using pineapple concentrate and manufacturing method thereof | |
KR102487280B1 (en) | Method of manufacturing sushi and sushi produced thereby | |
KR20160058205A (en) | Composition for removing hangover comprising fermented rice rinse water | |
KR102459653B1 (en) | Fermented antler using a natural fermented enzyme complex and a composition for preventing hair loss or promoting hair growth using the same | |
CN108450556A (en) | A kind of yoghourt-flavored fermentation dendrobe powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |